Aigen Investment Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6,732	Closed	-$240K	–	1029
2023 Q3	$240K	Buy	6,732 +2,312	+52%	+$91.6K	0.05%	605
2023 Q2	$204K	Buy	+4,420	New	+$205K	0.03%	616
2022 Q2	–	Sell	-13,982	Closed	-$1.01M	–	693
2022 Q1	$1.01M	Buy	+13,982	New	+$973K	0.18%	158
2021 Q3	–	Sell	-7,478	Closed	-$713K	–	625
2021 Q2	$713K	Buy	7,478 +5,499	+278%	+$573K	0.12%	179
2021 Q1	$225K	Sell	1,979 -9,338	-83%	-$1.27M	0.03%	505
2020 Q4	$1.57M	Sell	11,317 -5,133	-31%	-$609K	0.2%	127
2020 Q3	$1.35M	Buy	+16,450	New	+$1.36M	0.17%	186
2020 Q2	–	Sell	-22,207	Closed	-$987K	–	1200
2020 Q1	$987K	Sell	22,207 -4,788	-18%	-$249K	0.13%	216
2019 Q4	$1.15M	Buy	+26,995	New	+$1.11M	0.19%	147